Entries to the Challenge are officially closed. Thanks to those who applied!
It may be too late to participate in the Challenge, but if you missed the deadline and have a meaningful and disruptive solution you'd like to share, please get in touch with us at firstname.lastname@example.org.
Pfizer Oncology remains committed to the development of technology solutions to help enrich the lives of patients living with mBC and is always interested to hear more about true innovations.
Can you develop disruptive, technology-enabled solutions to help enrich the lives of patients living with mBC?
Advancing Care for Patients Living with mBC Challenge
Pfizer Oncology has partnered with Health 2.0 to bring you the Advancing Care for Patients Living with mBC Challenge. This global technology challenge seeks to close the gaps in mBC care and catalyze the development of meaningful solutions to support mBC patients along the care continuum and improve their overall quality of life.
The challenge is organized into 3 phases with goals that correlate to successive stages in technology development. The development to beta phase involves additional mentoring, funding, and support to get to a viable prototype.
Phase I - Concept
Phase I of the challenge involves developing creative concepts for tech-enabled solutions to help enrich the lives of patients living with mBC. Five semi-finalists will be selected from this round to advance to Phase II.
Phase II - Development
During Phase II, the 5 semi-finalists will receive mentorship from industry experts to guide the development of their solutions. A mid-challenge pitch during this phase will determine the 3 finalists who will advance to Phase III.
Phase III - Pitch
Phase III of the challenge will be a live pitch event during which the 3 finalists will demo their prototypes and pitch their business plans to a live audience. A grand winner and runner up will be selected.